引用次数
引用: 26,041
H-指数: 79
I10-指数 : 219
出版物: 599
Darkroom hepatitis after exposure to hydroquinone
AnnaK. Nowak , KeithB. Shilkin , GaryP. Jeffrey
The Lancet 345 ( 8958) 1187 -1187
13
1995
Bilateral thoracoscopy, mediastinoscopy and laparoscopy, in addition to CT, MRI and PET imaging, are essential to correctly stage and treat patients with mesothelioma prior to trimodality therapy.
John M. Alvarez , Arman Hasani , Amanda Segal , Greg Sterret
Anz Journal of Surgery 79 ( 10) 734 -738
21
2009
Delineating the Cellular Hierarchy of Glioblastoma and Gliosarcoma for Identification of Therapeutic Targets
Foteini Hassiotou , Tracy Seymour , Anna Nowak , Melanie Jackson
The FASEB Journal 29
2015
Guidelines for the diagnosis and treatment of malignant pleural mesothelioma
Nico Van Zandwijk , Christopher Clarke , Douglas Henderson , A William Musk
Journal of Thoracic Disease 5 ( 6)
134
2013
Current Management of Malignant Pleural Mesothelioma
Anna Nowak , Arman Hasani
Asia-Pacific Journal of Oncology & Hematology 1 ( 1) 1 -11
1
2009
Characterization of the effect of pleurodesis on FLT and FDG PET/CT imaging in malignant pleural mesothelioma (MPM)
Tatiana Segard , Laurence Morandeau , Anna Nowak , Roslyn Francis
The Journal of Nuclear Medicine 55 457 -457
1
2014
Evidence Based Medicine - teaching with clinical relevance in an undergraduate medical curriculum
Fiona Lake , Anna Nowak , Sandra Carr , G. Ryan
Focus on health professional education : a multi-disciplinary journal 11 ( 2) 45 -47
1
2010
PREDICTION MODELING USING ROUTINE CLINICAL PARAMETERS TO STRATIFY SURVIVAL IN MESOTHELIOMA PATIENTS UNDERGOING SURGERY
Anna Nowak , Nobuyuki Kondo , Fraser Brims , Fraser Brims
Respirology 22 67 -67
2017
The Improving Rural CancerOutcomes (IRCO) Trial: A Factorial Cluster-Randomised Controlled Trial of a Complex Intervention to Reduce Time to Diagnosis in Rural Cancer Patients in Western Australia
Jon Emery , Victoria Gray , Fiona M. Walter , Shelley Cheetham
Asia-pacific Journal of Clinical Oncology 13 83 -83
2017
Cisplatin and pemetrexed synergises with immunotherapy to result in cures in established murine malignant mesothelioma
Anna Nowak , Sathish Mahendran , Richard Lake , Robbert van der Most
Cancer Research 68 2073 -2073
4
2008
Participating in Exercise during Chemoradiotherapy Helps Patients Diagnosed with High Grade Glioma to Feel Stronger and Actively Involved in Their Fight Against Cancer: A Qualitative Study
Georgia Halkett , Eva Zopf , Daniel Galvao , Prue Cormie
Asia-pacific Journal of Clinical Oncology 13 215 -215
2017
11C- Methionine and 18F- Fluorothymidine PET Imaging in Suspected Residual or Recurrent Glioma
Tatiana Segard , Laurence Morandeau , Anna Nowak , Roslyn Francis
ANZ Nuclear Medicine 41 ( 2) 10
2010
The effects of gemcitabine on antigen-specific anti-tumour immunity in a murine tumour model
Anna Nowak
2002
Molecular Determinants of Autoimmunity and Immune Related Adverse Events in Advanced Cancer Patients Treated with Immune Checkpoint Inhibitors (Auto-Check Study)
Carola Vinuesa , Yoland Antill , Mustafa Khasraw , Anna Nowak
Asia-pacific Journal of Clinical Oncology 15 59 -59
2019
An evaluation of the QUAL-EC in the clinical care of patients with advanced cancer.
Anne Wilkinson , Susan Slatyer , Anna Nowak , Cathy Pienaar
Journal of Clinical Oncology 35 85 -85
2017
Randomised placebo-controlled cross-over study examining the role of anamorelin in mesothelioma (The ANTHEM study): rationale and protocol.
Siao Nge Hoon , Katrina Fyfe , Carolyn J Peddle-McIntyre , Samantha Bowyer
BMJ Open Respiratory Research 7 ( 1)
2
2020
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
Michael Weller , Nicholas Butowski , David D Tran , Lawrence D Recht
The Lancet Oncology 18 ( 10) 1373 -1385
758
2017
CTNI-23. IDH1/2wt ANAPLASTIC GLIOMAS OF THE EORTC RANDOMIZED PHASE III INTERGROUP CATNON TRIAL: OVERALL SURVIVAL RELATED TO TREATMENT, MGMT STATUS AND MOLECULAR FEATURES OF GLIOBLASTOMA
C Mircea S Tesileanu , Pim French , Sarah Erridge , Michael Vogelbaum
Neuro-Oncology 22 ( Supplement_2) ii47 -ii47
2020
An international, multicenter phase II trial of bortezomib in patients with hepatocellular carcinoma
Charles Erlichman , George P. Kim , Michelle R. Mahoney , Daniel Szydlo
Investigational New Drugs 30 ( 1) 387 -394
49
2012
COMMAND: A phase II randomized, double-blind, placebo-controlled, multicenter study of defactinib as maintenance therapy in subjects with malignant pleural mesothelioma that has not progressed on at least four cycles of pemetrexed/platinum therapy.
Dean Anthony Fennell , Paul Baas , Hedy Lee Kindler , Lee M. Krug
Journal of Clinical Oncology 32
4
2014